‘Blood Clotting’, side effect of Covid.
Scientists have found facts about the risk of developing a very rare blood clotting condition following vaccination against Covid.Scientists have revealed more knowledge about the risk of developing a very rare blood-clotting disorder after being vaccinated against COVID-19, according to a study.Based on health data from five European countries and the United States, this study assessed the risk of a condition called thrombosis with thrombocytopenia syndrome (TTS) after the first dose of Oxford AstraZeneca vaccine (same formulation as Covishield). has been shown to increase.
Based on health data from five European countries and the US, the study shows an increased risk of the condition, called thrombosis with thrombocytopenia syndrome (TTS), after first-dose of the Oxford-Astrazeneca vaccine (same as Covishield in formulation).Based on health data from five European countries and the US, the study shows an increased risk of the condition, called thrombosis with thrombocytopenia syndrome (TTS), after first-dose of the Oxford-Astrazeneca vaccine (same as Covishield in formulation).The study, published in The British Medical Journal (BMJ), also shows a trend towards an increased risk after the Janssen/Johnson & Johnson vaccine, compared with the Pfizer-BioNTech vaccine.
The researchers emphasized that the syndrome is extremely rare, but said the observed risks “should be considered when planning further vaccination campaigns and future vaccine development.”
